171 - Two Vax's and a MAB: What's New in RSV ...

In this episode, we review key updates from the 2026 ACC-AHA Guidelines on the Management of Dyslipidemia. Key Concepts The PREVENT ASCVD equation is now recommended to calculate ASCVD risk, with thresholds at 3%, 5%, and 10%. The previous 7.5% threshold for statin treatment is n ...  Show more

In this episode, we discuss the most important annual updates in the American Diabetes Association Guidelines, Standards of Care 2026, particularly focusing on changes in pharmacotherapy recommendations and the supporting evidence. Key Concepts A few existing agents now have ASCV ...  Show more

Welcome to a special series by Respiratory Exchange Addressing the Impact of RSV and Vaccine Hesitancy. In this series, we explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, childre ...  Show more

A vaccine pioneer tells us that shots to protect against RSV—a dangerous virus for babies and older people—are finally nearing approval. Learn more about your ad choices. Visit megaphone.fm/adchoices 

Sponsored by Pfizer Limited. Pfizer has had no involvement in the editorial component of this educational material. Editorial and content decisions were made solely by the RCGP.Respiratory syncytial virus (RSV) is an RNA virus which causes respiratory infections; the most signifi ...  Show more

Certain medicines listed in this activity may have either a US Food and Drug Administration (FDA) approval or have been given an Emergency Use Authorization (EUA) by the FDA to treat or prevent COVID-19. The information on COVID-19 is continually changing. The content in this act ...  Show more